View recent articles in Ovarian Cancer News
The largest global charitable organization dedicated to advancing ovarian cancer research while »
Comprehensive up-to-date coverage on ovarian cancer news, aggregated from sources all over the »
With only incremental improvements in ovarian cancer survival over the last 40 years, there is a »
The Web's Daily Resource for ovarian cancer news. Ovarian Cancer News Today is strictly a »
Corcept Therapeutics Incorporated (CORT) Q4 2019 Earnings Call Transcript - Motley Fool 
'My doctor told me I needed to lose weight. 10 months later, I was diagnosed with ovarian cancer' - 9Honey 
'Breakthrough' in Fertility Preservation for Breast Cancer Patient - MedPage Today 
In Nevada, caucusgoers are torn between who they believe can beat Trump and who they believe in - NBCNews.com 
Global Markets for Cell Therapies & Oncolytic Virus, Forecast to 2026 - Covering Melanoma, Breast, Ovarian & Prostate Cancer Applications - PRNewswire 
Test measures immune response to improve ovarian cancer diagnosis 
2020 National Conference Registration is Now Open 
Myriad Asks FDA to Approve myChoice CDx to Find Potential Lynparza Candidates 
Analysis of Cells in Fallopian Tube Can Help Classify Ovarian Cancer Subtypes, Study Says 
Scientists closer to finding the cell of origin for ovarian cancer 
Checkpoint Inhibitor Combination Well-tolerated, Effective in Ovarian Cancer Patients, Phase 1b Trial Shows 
PARP Inhibitors in Ovarian Cancer Treatment: What’s Next? 
New Trial Data Continue to Support DPX-Survivac in Treating Advanced Ovarian Cancer 
OCRA Earns 4-Star Charity Navigator Rating for Tenth Consecutive Year 
France Adds Rubraca for Relapsed Platinum-sensitive Ovarian Cancer to Reimbursed Treatments 
MRI tool can diagnose difficult cases of ovarian cancer 
Ovarian cancer: Current best practice 
Secondary surgery does not improve overall survival for recurrent ovarian cancer patients